Skip to main content

Table 4 Patients’ benefits related to current antihistamine treatment

From: Evaluation of patients’ expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study

 

mean ± SD*

Percentage of patients helped rather/a lot**

Weighted subscore m ± SD***

To be healed for all symptoms

3.1 ± 0.9

92.8%

0.21 ± 0.11

To no longer have a runny or blocked nose

3.0 ± 0.9

91.9%

0.19 ± 0.11

To be able to breathe through my nose more freely

3.0 ± 1.0

91.6%

0.19 ± 0.11

To not have sneezing impulses

2.9 ± 1.0

89.9%

0.17 ± 0.10

To not experience eye, nose or palate stinging anymore

2.8 ± 1.0

88.0%

0.16 ± 0.10

To be able to stay outdoors without symptoms

2.9 ± 1.0

90.0%

0.16 ± 0.10

To be able to engage in normal leisure activities

2.8 ± 1.1

85.3%

0.15 ± 0.08

To have a treatment which is easy to use

2.7 ± 1.2

81.2%

0.14 ± 0.10

To experience more enjoyment of life

2.6 ± 1.2

81.8%

0.13 ± 0.08

To not have burning or watery eyes anymore

2.8 ± 1.1

85.0%

0.15 ± 0.09

To have confidence in the therapy

2.6 ± 1.2

80.5%

0.13 ± 0.09

To be able to sleep better

2.5 ± 1.3

76.0%

0.12 ± 0.09

To feel less fatigued or groggy

2.4 ± 1.2

75.6%

0.11 ± 0.07

To be able to concentrate better at work

2.4 ± 1.2

74.1%

0.10 ± 0.07

To be more productive in everyday life

2.4 ± 1.2

75.7%

0.10 ± 0.06

To feel less burdened in your relationship

2.3 ± 1.3

72.1%

0.09 ± 0.07

To have fewer side effects

2.2 ± 1.3

69.3%

0.09 ± 0.07

To have no fear that the disease will become worse

2.2 ± 1.3

69.2%

0.09 ± 0.07

To feel more comfortable in public

2.3 ± 1.3

72.2%

0.09 ± 0.07

To be able to have a normal sex life

2.0 ± 1.4

59.5%

0.08 ± 0.07

To feel less depressed

2.0 ± 1.3

62.0%

0.07 ± 0.06

To feel less irritated

2.1 ± 1.3

63.8%

0.07 ± 0.06

To be less dependent on Doctor and clinic visits

2.0 ± 1.3

63.2%

0.07 ± 0.06

To spend less time on daily treatment

2.0 ± 1.4

60.1%

0.07 ± 0.06

To have fewer out-of-pocket treatment expenses

1.8 ± 1.4

54.9%

0.06 ± 0.06

Global weighted PBI

2.7 ± 0.8

Patients with global PBI ≥1

2956 (96.5%)

  1. Analysis of the Patient Benefits Questionnaires filled-in after antihistamine treatment. Patient’s benefits are ordered by decreasing importance of the corresponding need. Treatment-related benefits are scaled from 0 ‘did not help at all’ to 4 ‘helped a lot’. *Data are described as mean ± SD. **Percentage of patients with the need achieved by treatment from ‘rather helped’ to ‘helped a lot’ among afflicted patients at treatment initiation; ***PBI subscores weighted by the relative amount of the corresponding patient’s need.
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us